LaiT.Y., LamC.P., LukF.O.et al.Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy. J. Ocul. Pharmacol. Ther., 26:91–95. 2010.
2.
LeeS.Y., KimJ.G., JoeS.G.et al.The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy. Korean J. Ophthalmol., 22:92–99. 2008.
3.
KimS.W., OhJ., OhI.K.et al.Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy. Ophthalmic Surg. Lasers Imaging, 40:300–303. 2009.
4.
KokameG.T., YeungL., LaiJ.C.et al.Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results. Br. J. Ophthalmol., 94:297–330. 2010.
